Thermodynamic behavior of glassy state of structurally related compounds.

Thermodynamic properties of amorphous pharmaceutical forms are responsible for enhanced solubility as well as poor physical stability. The present study was designed to investigate the differences in thermodynamic parameters arising out of disparate molecular structures and associations for four structurally related pharmaceutical compounds--celecoxib, valdecoxib, rofecoxib, and etoricoxib. Conventional and modulated temperature differential scanning calorimetry were employed to study glass forming ability and thermodynamic behavior of the glassy state of model compounds. Glass transition temperature of four glassy compounds was in a close range of 327.6-331.8 K, however, other thermodynamic parameters varied considerably. Kauzmann temperature, strength parameter and fragility parameter showed rofecoxib glass to be most fragile of the four compounds. Glass forming ability of the compounds fared similar in the critical cooling rate experiments, suggesting that different factors were determining the glass forming ability and subsequent behavior of the compounds in glassy state. A comprehensive understanding of such thermodynamic facets of amorphous form would help in rationalizing the approaches towards development of stable glassy pharmaceuticals.

[1]  R. Hatley.  Glass fragility and the stability of pharmaceutical preparations--excipient selection. , 1997, Pharmaceutical development and technology.

[2]  Bruno C. Hancock,et al.  CHARACTERIZATION OF THE TIME SCALES OF MOLECULAR MOTION IN PHARMACEUTICALLY IMPORTANT GLASSES , 1999 .

[3]  I. Hodge.  Strong and fragile liquids — a brief critique , 1996 .

[4]  W. Kauzmann.  The Nature of the Glassy State and the Behavior of Liquids at Low Temperatures. , 1948 .

[5]  C. Angell,et al.  Glass transition temperatures for simple molecular liquids and their binary solutions , 1978 .

[6]  D. Mishra,et al.  Determination of the glass properties of D-mannitol using sorbitol as an impurity. , 1998, Journal of pharmaceutical sciences.

[7]  Bruno C. Hancock,et al.  Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. , 1994, Journal of pharmaceutical sciences.

[8]  Deliang Zhou,et al.  Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. , 2002, Journal of pharmaceutical sciences.

[9]  Patrick J. Marsac,et al.  A Comparison of the Physical Stability of Amorphous Felodipine and Nifedipine Systems , 2006, Pharmaceutical Research.

[10]  G. Tammann,et al.  Die Abhängigkeit der Viscosität von der Temperatur bie unterkühlten Flüssigkeiten , 1926 .

[11]  G. Fulcher,et al.  ANALYSIS OF RECENT MEASUREMENTS OF THE VISCOSITY OF GLASSES , 1925 .

[12]  C. Angell.  Relaxation in liquids, polymers and plastic crystals — strong/fragile patterns and problems☆ , 1991 .

[13]  C A Angell,et al.  The old problems of glass and the glass transition, and the many new twists. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Karis,et al.  Organic monomeric glass formation by substituted ethylenediamine , 1995 .

[15]  J. Zarzycki,et al.  Glasses and the vitreous state , 1991 .

[16]  C. A. Mitchell,et al.  Crystallization and Polymorphism of Conformationally Flexible Molecules: Problems, Patterns, and Strategies , 2000 .

[17]  Deliang Zhou,et al.  A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses. , 2007, Journal of pharmaceutical sciences.

[18]  C. Angell,et al.  Nonexponential relaxations in strong and fragile glass formers , 1993 .

[19]  Aditya Mohan Kaushal,et al.  Amorphous drug delivery systems: molecular aspects, design, and performance. , 2004, Critical reviews in therapeutic drug carrier systems.

[20]  P. Royall,et al.  The relevance of the amorphous state to pharmaceutical dosage forms: glassy drugs and freeze dried systems. , 1999, International journal of pharmaceutics.

[21]  Lieve Naesens,et al.  Thermal characterization of the antiviral drug UC-781 and stability of its glass , 2001 .

[22]  H. Vogel,et al.  Das Temperaturabhangigkeitsgesetz der Viskositat von Flussigkeiten , 1921 .

[23]  Bruno C. Hancock,et al.  Molecular mobility of amorphous pharmaceuticals determined using differential scanning calorimetry , 2001 .

[24]  I. Hodge.  Enthalpy relaxation and recovery in amorphous materials , 1994 .

[25]  George Zografi,et al.  The use of thermal methods for predicting glass-former fragility , 2001 .

[26]  L Yu,et al.  Amorphous pharmaceutical solids: preparation, characterization and stabilization. , 2001, Advanced drug delivery reviews.

[27]  E. C. Subbarao,et al.  Advances in Ceramics , 1981 .

[28]  Bruno C. Hancock,et al.  Estimating the Critical Molecular Mobility Temperature (TK) of Amorphous Pharmaceuticals , 1998, Pharmaceutical Research.